Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: A prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors

Journal of Gastrointestinal Surgery

Volumn 7, Issue 1, 2003, Pages 1-11

  Nguyen, Tom C ^a   Sohn, Taylor A ^a   Cameron, John L ^a   Lillemoe, Keith D ^a   Campbell, Kurtis A ^a   Coleman, JoAnn ^a   Sauter, Patricia K ^a   Abrams, Ross A ^a   Hruban, Ralph H ^a   Yeo, Charles J ^a,b   Warshaw, ^c   Aranha, G V ^c   Maggard, M ^c   Bastidas, J A ^c   Traverso, L William ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c NONE

Author keywords

Pancreaticoduodenectomy; Periampullary adenocarcinoma; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; DIARRHEA; FEMALE; FOLLOW UP; HEALTH STATUS; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOMES RESEARCH; PANCREATICODUODENECTOMY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZATION; STATISTICAL ANALYSIS; TREATMENT INDICATION; VATER PAPILLA CARCINOMA; WEIGHT REDUCTION; ADENOCARCINOMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; GASTRECTOMY; LYMPHADENECTOMY; METHODOLOGY; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETROPERITONEUM; SURVIVAL RATE;

ADENOCARCINOMA; AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RETROPERITONEAL SPACE; SURVIVAL RATE;

EID: 0037267812     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(02)00187-7     Document Type: Article

References (31)

1. Velanovich V. The quality of quality of life studies in general surgical journals. J Am Coll Surg. 193:2001;288-296.
2. Velanovich V. Using quality-of-life instruments to assess surgical outcomes. Surgery. 126:1999;1-4.
3. Sohn T.A., Yeo C.J., Cameron J.L.et al. Resected adenocarcinoma of the pancreas - 616 patients. Results, outcomes, and prognostic indicators J Gastrointest Surg. 4:2000;567-579.
4. Yeo C.J., Sohn T.A., Cameron J.L.et al. Periampullary adenocarcinoma. Analysis of 5-year survivors Ann Surg. 227:1998;821-831.
5. Conlon K.C., Klimstra D.S., Brennan M.F. Long-term survival after curative resection and pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg. 223:1996;273-289.
6. Traverso L.W., Kawarada Y., Isaji S.et al. Extended lymphadenectomy during pancreaticoduodenectomy for cancer of the pancreas. Summary of "How I Do It" Session J Gastrointest Surg. 4:2000;225-232.
7. Yeo C.J., Cameron J.L. Extended nodal clearance for pancreatic cancer. Asian J Surg. 24:2001;203-208.
8. Satake K., Niskiwaki H., Yokomatsu H.et al. Surgical curability and prognosis for standard versus extended resections for T1 carcinoma of the pancreas. Surg Gynecol Obstet. 175:1992;259-265.
9. Pedrazzoli S., DiCarlo V., Dionigi R.et al. Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. A multicenter, prospective, randomized study. Ann Surg. 228:1998;508-517.
10. Iacuno C., Bortolasi L., Facci E.et al. Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy? J Gastrointest Surg. 1:1997;446-453.
11. Henne-Bruns D., Vogel I., Lüttges J.et al. Surgery for ductal adenocarcinoma of the pancreatic head. Staging, complications, and survival after regional versus extended lymphadenectomy World J Surg. 24:2000;595-602.
12. Yeo C.J., Cameron J.L., Sohn T.A.et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. Comparison of morbidity and mortality and short-term outcome Ann Surg. 229:1999;613-624.
13. Yeo C.J., Cameron J.L., Lillemoe K.D.et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2. Randomized controlled trial evaluating survival, morbidity, and mortality Ann Surg. 236:2002;355-366.
14. Henne-Bruns D., Vogel I., Luttges J.et al. Ductal adenocarcinoma of the pancreas head. Survival after regional versus extended lymphadenectomy Hepatogastroenterology. 45:1998;855-866.
15. Nagakawa T., Nagamori M., Futakami F.et al. Results of extensive surgery for pancreatic carcinoma. Cancer. 77:1996;640-645.
16. McLeod R.S., Taylor B.R., O'Connor B.I.et al. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg. 169:1995;179-185.
17. Patel A.G., Toyoma M.T., Kusske A.M.et al. Pylorus-preserving Whipple resection for pancreatic cancer. Is it any better? Arch Surg. 130:1995;838-842.
18. Melvin W.S., Buekers K.S., Muscarella P.et al. Outcome analysis of long-term survivors following pancreaticoduodenectomy. J Gastrointest Surg. 2:1998;72-78.
19. Kokoska E.R., Stapleton D.R., Virgo K.S.et al. Quality of life measurements do not support palliative pancreatic cancer treatments. Int J Oncol. 13:1998;1323-1329.
20. Wenger F.A., Jacobi C.A., Haubold K.et al. Gastrointestinal quality of life after duodenenopancreatectomy in pancreatic cancer. Preliminary results of a prospective-randomized trial. PD vs PPPD. Chirurg. 70:1999;1454-1459.
21. Huang J.J., Yeo C.J., Sohn T.A.et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg. 231:2000;890-898.
22. Yeo C.J., Barry M.K., Sauter P.K.et al. Erythromycin accelerates gastric emptying following pancreaticoduodenectomy. A prospective, randomized placebo controlled trial Ann Surg. 218:1993;229-238.
23. Yeo C.J., Abrams R.A., Grochow L.B.et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma. Postoperative adjuvant chemoradiation improves survival. A prospective, single institution experience Ann Surg. 225:1997;621-636.
24. Abrams R.A., Grochow L.B., Chakravarthy A.et al. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma. Survival results and observations regarding patterns of failure, radiotherapy dose and CA 19-9 levels Int J Radiat Oncol Biol Phys. 44:1999;1039-1046.
25. Chakravarthy A., Abrams R.A., Yeo C.J.et al. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma. Acceptable toxicity and improved 1-year disease-free survival Int J Radiat Oncol Biol Phys. 48:2000;1089-1096.
26. Yeo C.J., Sohn T.A., Cameron J.L.et al. Periampullary adenocarcinoma. Analysis of 5-year survivors Ann Surg. 227:1998;821-831.
27. Cella D.F., Tulsky D.S., Gray G.et al. The functional assessment of cancer therapy scale. Development and validation of the general measure J Clin Oncol. 11:1993;570-579.
28. Overcash J., Extermann M., Parr J.et al. Validity and reliability of the FACT-G scale use in the older person with cancer. Am J Clin Oncol. 24:2001;591-596.
29. Heffernan N., Cella D., Webster K.et al. Measuring health-related quality of life in patients with hepatobiliary cancers. The functional assessment of cancer therapy-hepatobiliary questionnaire J Clin Oncol. 20:2002;2229-2239.
30. Padilla G., Present C., Grant M.et al. Quality of life index for patients with cancer. Res Nurs Health. 6:1983;117-126.
31. Present C., Klahr C., Hogan L. Evaluating quality of life in oncology patients. Pilot observations Oncol Nurs Forum. 8:1981;26-30.